LabCorp and Capital Health Enter Comprehensive Laboratory Partnership

Collaboration Will Enhance and Streamline Laboratory Services for Patients and Physicians in Central New Jersey and Lower Bucks County, Pennsylvania BURLINGTON, N.C. & TRENTON, N.J. --(BUSINESS WIRE)--Nov. 1, 2017-- LabCorp® (NYSE: LH), a leading global life sciences company, and Capital Health ,

LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance

Q3 Net revenue of $2.6 billion , up 10% over last year Q3 Diluted EPS of $1.74 , up 2% from last year; Q3 Adjusted EPS of $2.46 , up 9% over last year 2017 Adjusted EPS guidance increased to $9.40 to $9.60 , up 6% to 9% over 2016 2017 Free Cash Flow guidance increased to $970 million to $1,010

Covance Recognized with Frost & Sullivan Asia Pacific CRO Customer Value Leadership Award

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 16, 2017-- LabCorp (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development business (Covance) has been awarded the 2017 Frost & Sullivan Asia Pacific CRO Customer Value Leadership Award.

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 2, 2017-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject

LabCorp Objects to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests; Calls for Delay in Implementation to Avoid Significant Harm to Medicare Beneficiaries

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 25, 2017-- LabCorp (NYSE: LH), a leading global life sciences company, today issued the following response to the Sept. 22 publication by the Centers for Medicare and Medicaid Services (CMS) of proposed 2018 Medicare reimbursement rates for clinical

LabCorp Presents Nine Studies, Including Novel Research on Improving Genetic Counseling Quality, at the National Society of Genetic Counselors Annual Conference

LabCorp’s Integrated Genetics Specialty Laboratory Leverages Decades of Experience in Genetics Research and Practice to Improve Health and Improve Lives BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 14, 2017-- LabCorp (NYSE: LH), a leading global life sciences company, announced today that Integrated

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 11, 2017-- LabCorp® (NYSE: LH) announced today that for the period of September 11, 2017 to March 9, 2018 , its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent

LabCorp Named Among “The World’s Most Innovative Companies” in Forbes’ 2017 Ranking

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 7, 2017-- LabCorp® (NYSE: LH), a leading global life sciences company, has been named to Forbes’ 2017 ranking of “The World’s Most Innovative Companies.” “Innovation in guiding patient care is what we do at LabCorp, so being recognized as one of the world’s

LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 5, 2017-- LabCorp® (NYSE:LH) today announced it will participate at the Morgan Stanley Global Healthcare Conference . LabCorp’s presentation is planned for Tuesday, September 12, 2017 , at 8:35 am (ET) . A live audio webcast will be available via the Company

LabCorp Completes Acquisition of Chiltern

Strengthens LabCorp’s Position as a Global Life Sciences Company with Leading Diagnostics and Drug Development Businesses BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 1, 2017-- LabCorp® (NYSE: LH), a leading global life sciences company, has completed its previously announced acquisition of Chiltern,